NANOG and sarcoma: PIK3R3 shRNA in sarcoma spheroids also resulted in decreased expression of CD133 and Nanog as determined by Western blot and immunostaining, but did not affect levels of Sox2, Oct-4, and c-Myc (Fig. 2C–D).